Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Hum Immunol. 2010 Mar 5;71(5):496–504. doi: 10.1016/j.humimm.2010.02.007

Figure 1. Lymphocyte counts remain unchanged in prostate cancer patients treated with androgen deprivation.

Figure 1

Blood was collected from patients immediately prior to treatment and after 6 (n=21) and 12 months (n=14 of these 21) of ADT. Shown are the percent change from baseline in absolute lymphocytes per microliter (panel A), and the percent change from baseline in the CD4+ or CD8+ T cells among CD3+ T cells (panel B).